Patents by Inventor Monika POLEWSKI

Monika POLEWSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11583509
    Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: February 21, 2023
    Assignee: CITY OF HOPE
    Inventors: Samuel Rahbar, James L. Figarola, Christopher Lincoln, David Horne, Rachael Mooney, Monika Polewski, George Somlo, Lixin Yang, Sanjay Awasthi, Sharad Singhal, Jyotasana Singhal
  • Publication number: 20220023240
    Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.
    Type: Application
    Filed: November 6, 2017
    Publication date: January 27, 2022
    Inventors: Samuel RAHBAR, James L. FIGAROLA, Christopher LINCOLN, David HORNE, Rachael MOONEY, Monika POLEWSKI, George SOMLO, Lixin YANG, Sanjay AWASTHI, Sharad SINGHAL, Jyotasana SINGHAL
  • Patent number: 10029991
    Abstract: One aspect of the disclosure relates to derivatives of aryl and heterocyclic ureido aryl and heterocyclic carboxamido isobutyric acids, dichlorophenyl urea, curcumin, and 1,3-diazetidine-2,4-dione, and pharmaceutical compositions thereof. The derivatives disclosed herein can modulate development of adipocytes and various cancer cells, including resistant cancer cells and cancer stem cells. Another aspect of the disclosure relates to the use of the derivatives and pharmaceutical compositions disclosed herein in treatment of obesity and various cancers.
    Type: Grant
    Filed: July 29, 2013
    Date of Patent: July 24, 2018
    Assignee: CITY OF HOPE
    Inventors: Samuel Rahbar, James L. Figarola, Christopher Lincoln, David Horne, Rachael Mooney, Monika Polewski, George Somlo, Lixin Yang, Sanjay Awasthi
  • Patent number: 9808434
    Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.
    Type: Grant
    Filed: June 4, 2016
    Date of Patent: November 7, 2017
    Assignee: CITY OF HOPE
    Inventors: Samuel Rahbar, James L. Figarola, Christopher Lincoln, David Horne, Rachael Mooney, Monika Polewski, George Somlo, Lixin Yang, Sanjay Awasthi, Sharad Singhal, Jyotasana Singhal
  • Publication number: 20160354327
    Abstract: One aspect of the disclosure relates to the use of derivatives of dichlorophenyl urea for treating cancers.
    Type: Application
    Filed: June 4, 2016
    Publication date: December 8, 2016
    Inventors: Samuel RAHBAR, James L. Figarola, Christopher Lincoln, David Horne, Rachael Mooney, Monika Polewski, George Somlo, Lixin Yang
  • Publication number: 20140162996
    Abstract: One aspect of the disclosure relates to derivatives of aryl and heterocyclic ureido aryl and heterocyclic carboxamido isobutyric acids, dichlorophenyl urea, curcumin, and 1,3-diazetidine-2,4-dione, and pharmaceutical compositions thereof. The derivatives disclosed herein can modulate development of adipocytes and various cancer cells, including resistant cancer cells and cancer stem cells. Another aspect of the disclosure relates to the use of the derivatives and pharmaceutical compositions disclosed herein in treatment of obesity and various cancers.
    Type: Application
    Filed: July 29, 2013
    Publication date: June 12, 2014
    Applicant: CITY OF HOPE
    Inventors: Samuel RAHBAR, James L. FIGAROLA, Christopher LINCOLN, David HORNE, Rachael MOONEY, Monika POLEWSKI, George SOMLO, Lixin YANG